期刊文献+

功能性垂体腺瘤经蝶窦术后的随访研究 被引量:1

Follow-up of transsphenoidal surgery for secreting pituitary adenomas
暂未订购
导出
摘要 目的 :探讨经蝶入路手术治疗泌乳素 (PRL)腺瘤、生长激素 (GH)腺瘤和促肾上腺皮质激素 (ACTH)腺瘤的效果及手术前后血清内分泌学变化。方法 :我科 1995年 10月至 2 0 0 2年 9月用显微外科手术治疗垂体腺瘤 2 5 4例 ,其中具有完整血清内分泌学检查结果和 MRI随访资料的功能性垂体腺瘤 14 3例 ,其中 PRL腺瘤 6 1例 ,GH腺瘤 5 0例 ,ACTH腺瘤 32例。平均随访时间为 2 .3年。结果 :GH腺瘤和 ACTH腺瘤的全切率明显高于 PRL腺瘤 (P<0 .0 1) ,GH腺瘤与 ACTH腺瘤相差不显著 (P>0 .0 5 )。肿瘤的全切率与肿瘤的大小相关 (P<0 .0 5 ) ,微腺瘤全切率高于大腺瘤。肿瘤全切率与肿瘤侵袭性明显相关(P<0 .0 5 )。PRL腺瘤的复发率明显高于 GH腺瘤和 ACTH腺瘤 (P<0 .0 5 )。侵袭性垂体腺瘤的复发率高于非侵袭性垂体腺瘤 (P<0 .0 5 )。术后血清内分泌水平均全面降低。结论 :GH腺瘤与 ACTH腺瘤的治疗效果优于 PRL腺瘤。 Objective:To study the effectiveness of transsphenoidal surgery for GH ,ACTH ,and PRL secreting pituitary adenomas.Methods:Among 254 patients with diagnosed pituitary adenomas from Oct.1995 to Sep.2002,143 cases of secreting pituitary adenomas(56.3%) had the full endocrinological testing and MRI follow up information (61 PRL ,50 GH ,32 ACTH ).The median follow up time was 2.3 years.Results:The total removal rate for PRL secreting adenomas (34.4%) was significantly lower than that for GH (68.0%) and ACTH secreting (78.1%) adenomas( P <0.01).Total removal rate was correlated with tumor size and invasiveness:that of microadenomas was higher than macroadenomas( P <0.05) and that of noninvasive adenomas was higher than invasive adenomas( P <0.05).The recurrence rate of PRL secreting adenomas was higher than that of ACTH and GH secreting adenomas ( P <0.05); that of invasive adenomas was higher than noninvasive adenomas( P <0.05).Hormonal level in secreting pituitary adenomas had an overall decrease postoperatively.Conclusion:The therapeutic effects of GH and ACTH secreting pituitary adenomas are better than that of PRL secreting adenomas.The therapeutic effects of secreting pituitary adenomas are related to their endocrinological feature and invasiveness.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第8期840-842,共3页 Academic Journal of Second Military Medical University
关键词 功能性垂体腺瘤 经蝶窦手术 术后 随访研究 泌乳素腺瘤 生长激素腺瘤 促肾上腺皮质激素腺瘤 PRL secreting adenomas GH secreting adenomas ACTH secreting adenomas transsphenoidal surgery
  • 相关文献

参考文献7

  • 1Kristof RA, Schramm J, Redel L,et al. Endocrinological outcome following first time transsphenoidal surgery for GH-,ACTH-,and PRL secreting pituitary adenomas[J]. Acta Neurochir (Wien) ,2002,144(6) :555-561.
  • 2Bochicchio D, Losa M,Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group[J]. J Clin Endocrinol Metab,1995,80(11):3114-3120.
  • 3Nomikos P,Buchfelder M, Fahlbusch R. Current management of prolactinomas[J].J Neurooncol, 54(2) : 139-150.
  • 4Ozgen T,Oruckaptan HH,Ozcan OE,et al. Prolactin secreting pituitary adenomas :analysis of 429 surgically treated patients,effect of adjuvant treatment modalities and review of the literature[J]. Acta Neurochir(Wien), 1999,141(12) : 1287-1294.
  • 5Tyrrell JB, Lamborn KR,Hannegan LT,et al. Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results [J]. Neurosurgery, 1999,44(2): 254- 263.
  • 6Laws ER Jr. Multiple pituitary adenomas [J]. J Neurosurg,2000,93(5):909-911.
  • 7Turner HE,Adams CBT, Wass AH. Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists [J]. Eur J Endocrinol, 1999,140(1): 43-47.

同被引文献12

  • 1李改峰,张兴祥,孟捷,闫斌,钟学启,冯祖荫,常近乐.垂体腺瘤术后复发的相关因素[J].中国误诊学杂志,2004,4(10):1601-1602. 被引量:1
  • 2陶蔚,田宇,王任直.垂体腺瘤的影像学与内分泌学检查[J].中国微侵袭神经外科杂志,2005,10(1):42-44. 被引量:1
  • 3Losa M,Mortini P,Barzaghi R,et al.Surgical treatment of prolactin-secreting pituitary adenomas:early results and long-term outcome[J].J Clin Endocrinol Metab,2002; 87(7):3180-3186.
  • 4Ozgen T,Oruckaptan HH,Ozcan OE,et al.Prolactin secreting pituitary adenomas:analysis of 429 surgically treated patients,effect of adjuvant treatment modalities and review of the literature[J].Acta Neurochir (Wien),1999; 141(12):1287-1294.
  • 5Kreutzer J,Fahlbusch R.Diagnosis and treatment of pituitary tumors[J].Curr Opin Neurol,2004; 17(6):693-703.
  • 6Esposito V,Santoro A,Minniti G,et al.Transsphenoidal adenomectomy for GH-,PRL-and ACTH-secreting pituitary tumours:outcome analysis in a series of 125 patients[J].Neurol Sci,2004; 25(5):251-256.
  • 7Dickerman RD,Oldfield EH.Basis of persistent and recurrent Cushing disease:an analysis of findings at repeated pituitary surgery[J].J Neurosurg,2002; 97(6):1343-1349.
  • 8Parl FF,Cruz VE,Cobb CA,et al.Late recurrence of surgically removed prolactinomas[J].Cancer,1986; 57(12):2422-2466.
  • 9Nomikos P,Buchfelder M,Fahlbusch R.Current management of prolactinomas[J].J Neurooncol,2001; 54(2):139-150.
  • 10Serri O,Rasio E,Beauregard H,et al.Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma[J].N Engl J Med,1983; 309(5):280-283.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部